These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37114738)

  • 1. Novel insights into diminished cardiac reserve in non-obstructive hypertrophic cardiomyopathy from four-dimensional flow cardiac magnetic resonance component analysis.
    Ashkir Z; Johnson S; Lewandowski AJ; Hess A; Wicks E; Mahmod M; Myerson S; Ebbers T; Watkins H; Neubauer S; Carlhäll CJ; Raman B
    Eur Heart J Cardiovasc Imaging; 2023 Aug; 24(9):1192-1200. PubMed ID: 37114738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct mitral regurgitation quantification in hypertrophic cardiomyopathy using 4D flow CMR jet tracking: evaluation in comparison to conventional CMR.
    Gupta AN; Avery R; Soulat G; Allen BD; Collins JD; Choudhury L; Bonow RO; Carr J; Markl M; Elbaz MSM
    J Cardiovasc Magn Reson; 2021 Dec; 23(1):138. PubMed ID: 34865629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional haemodynamics in patients with obstructive and non-obstructive hypertrophic cardiomyopathy assessed by cardiac magnetic resonance.
    Allen BD; Choudhury L; Barker AJ; van Ooij P; Collins JD; Bonow RO; Carr JC; Markl M
    Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):29-36. PubMed ID: 25108915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging.
    Huang X; Yue Y; Wang Y; Deng Y; Liu L; Di Y; Sun S; Chen D; Fan L; Cao J
    Cardiovasc Ultrasound; 2018 Oct; 16(1):23. PubMed ID: 30285887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular diastolic function assessed with cardiovascular magnetic resonance imaging and exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy.
    Małek LA; Chojnowska L; Kłopotowski M; Misko J; Dabrowski M; Kuśmierczyk-Droszcz B; Maczyńska R; Piotrowicz E; Ruzyłło W
    Kardiol Pol; 2009 Jan; 67(1):1-6; discussion 7-8. PubMed ID: 19253184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function.
    Mentias A; Raeisi-Giglou P; Smedira NG; Feng K; Sato K; Wazni O; Kanj M; Flamm SD; Thamilarasan M; Popovic ZB; Lever HM; Desai MY
    J Am Coll Cardiol; 2018 Aug; 72(8):857-870. PubMed ID: 30115224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4D flow MRI and T1 -Mapping: Assessment of altered cardiac hemodynamics and extracellular volume fraction in hypertrophic cardiomyopathy.
    van Ooij P; Allen BD; Contaldi C; Garcia J; Collins J; Carr J; Choudhury L; Bonow RO; Barker AJ; Markl M
    J Magn Reson Imaging; 2016 Jan; 43(1):107-14. PubMed ID: 26227419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy.
    Mahmod M; Raman B; Chan K; Sivalokanathan S; Smillie RW; Samat AHA; Ariga R; Dass S; Ormondroyd E; Watkins H; Neubauer S
    J Cardiovasc Magn Reson; 2022 Jun; 24(1):36. PubMed ID: 35692049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular magnetic resonance detects microvascular dysfunction in a mouse model of hypertrophic cardiomyopathy.
    Ku MC; Kober F; Lai YC; Pohlmann A; Qadri F; Bader M; Carrier L; Niendorf T
    J Cardiovasc Magn Reson; 2021 May; 23(1):63. PubMed ID: 34053450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of mitral regurgitation in patients with hypertrophic cardiomyopathy using aortic and pulmonary flow data: impacts of left ventricular outflow tract obstruction and different left ventricular segmentation methods.
    Śpiewak M; Kłopotowski M; Gawor M; Kubik A; Kowalik E; Miłosz-Wieczorek B; Dąbrowski M; Werys K; Mazurkiewicz Ł; Kożuch K; Polańska-Skrzypczyk M; Petryka-Mazurkiewicz J; Klisiewicz A; Bilińska ZT; Grzybowski J; Witkowski A; Marczak M
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):105. PubMed ID: 29268761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Test-retest variability of left ventricular 4D flow cardiovascular magnetic resonance measurements in healthy subjects.
    Stoll VM; Loudon M; Eriksson J; Bissell MM; Dyverfeldt P; Ebbers T; Myerson SG; Neubauer S; Carlhäll CJ; Hess AT
    J Cardiovasc Magn Reson; 2018 Mar; 20(1):15. PubMed ID: 29499706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of left ventricular blood flow kinetic energy in patients with hypertension by four-dimensional flow cardiovascular magnetic resonance imaging: a preliminary study.
    Peng K; Zhang X; Hua T; Wan L; Xiao F; Zhang X; Liu Y; Xu Y; Tang H; Wang S; Tang G
    Eur Radiol; 2023 Jul; 33(7):4676-4687. PubMed ID: 36826498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diastolic dysfunction assessed by cardiac magnetic resonance imaging tissue tracking on normal-thickness wall segments in hypertrophic cardiomyopathy.
    Qiao J; Zhao P; Lu J; Huang L; Ma X; Zhou X; Xia L
    BMC Med Imaging; 2023 Jan; 23(1):7. PubMed ID: 36624416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Chacko BR; Karur GR; Connelly KA; Yan RT; Kirpalani A; Wald R; Jimenez-Juan L; Jacob JR; Deva DP; Yan AT
    Indian Heart J; 2018; 70(1):75-81. PubMed ID: 29455792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diastolic inflow is associated with inefficient ventricular flow dynamics in Fontan patients.
    Stone ML; Schäfer M; DiMaria MV; von Alvensleben JC; Campbell DN; Jaggers J; Mitchell MB
    J Thorac Cardiovasc Surg; 2022 Mar; 163(3):1195-1207. PubMed ID: 34429192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4D-flow cardiac magnetic resonance-derived vorticity is sensitive marker of left ventricular diastolic dysfunction in patients with mild-to-moderate chronic obstructive pulmonary disease.
    Schäfer M; Humphries S; Stenmark KR; Kheyfets VO; Buckner JK; Hunter KS; Fenster BE
    Eur Heart J Cardiovasc Imaging; 2018 Apr; 19(4):415-424. PubMed ID: 28460004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right ventricular hypertrophy is associated with cardiovascular events in hypertrophic cardiomyopathy: evidence from study with magnetic resonance imaging.
    Nagata Y; Konno T; Fujino N; Hodatsu A; Nomura A; Hayashi K; Nakamura H; Kawashiri MA; Yamagishi M
    Can J Cardiol; 2015 Jun; 31(6):702-8. PubMed ID: 25935883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMR feature tracking strain patterns and their association with circulating cardiac biomarkers in patients with hypertrophic cardiomyopathy.
    Cavus E; Muellerleile K; Schellert S; Schneider J; Tahir E; Chevalier C; Jahnke C; Radunski UK; Adam G; Kirchhof P; Blankenberg S; Lund GK; Avanesov M; Patten M
    Clin Res Cardiol; 2021 Nov; 110(11):1757-1769. PubMed ID: 33779809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Diastolic Flow Patterns and Kinetic Energy in Subtle Left Ventricular Remodeling and Dysfunction Detected by 4D Flow MRI.
    Svalbring E; Fredriksson A; Eriksson J; Dyverfeldt P; Ebbers T; Bolger AF; Engvall J; Carlhäll CJ
    PLoS One; 2016; 11(8):e0161391. PubMed ID: 27532640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Value of Myocardial Fibrosis Parameters Derived from Cardiac Magnetic Resonance Imaging in Risk Stratification for Patients with Hypertrophic Cardiomyopathy.
    Yu T; Cai Z; Yang Z; Lin W; Su Y; Li J; Xie S; Shen J
    Acad Radiol; 2023 Sep; 30(9):1962-1978. PubMed ID: 36604228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.